In the past decade, catheter ablation techniques and implantable devic
es have revolutionized the treatment of ventricular arrhythmias, junct
ional arrhythmias, and atrial flutter. For most patients presenting wi
th atrial fibrillation (AF), the treatment available today is similar
to that used a century ago, although nonpharmacologic strategies of th
erapy have begun to emerge for selected cases. There have been importa
nt recent advances in our understanding of the pathophysiology of AF a
nd its complications? and it may be possible to improve patient manage
ment by refinement of the way in which current drugs are used.